Guidelines for better harm reduction: Evaluating implementation of best practice recommendations for needle and syringe programs (NSPs)

International Journal of Drug Policy

Volumn 22, Issue 1, 2011, Pages 34-40

  Strike, Carol ^a   Watson, Tara Marie ^a   Lavigne, Paul ^a   Hopkins, Shaun ^a   Shore, Ron ^a   Young, Don ^a   Leonard, Lynne ^a   Millson, Peggy ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Best practice recommendations; Evaluation; Harm reduction; Needle and syringe programs

Indexed keywords

ARTICLE; DECISION MAKING; DRUG USE; FUNDING; HARM REDUCTION; HEALTH BEHAVIOR; HEALTH PROGRAM; HEALTH SERVICE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEEDLE AND SYRINGE PROGRAM; POLICY; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK REDUCTION;

BENCHMARKING; DATA COLLECTION; DRUG USERS; HARM REDUCTION; HIV INFECTIONS; HUMANS; NEBULIZERS AND VAPORIZERS; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; NEEDLES; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 79151473795     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.03.007     Document Type: Article

References (42)

1. Bluthenthal R.N., Ridgeway G., Schell T., Anderson R., Flynn N.M., Kral A.H. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction 2007, 102(4):638-646.
2. Boyd S., Johnson J.L., Moffat B. Opportunities to learn and barriers to change: Crack cocaine use in the Downtown Eastside of Vancouver. Harm Reduction Journal 2008, 5(34). 10.1186/1477-7517-5-34.
3. Burrows D. High coverage sites: HIV prevention among injecting drug users in transitional and developing countries: Case studies (UNAIDS Best Practice Collection) 2006, Retrieved from Joint United Nations Programme on HIV/AIDS (UNAIDS) website:. http://data.unaids.org/Publications/IRC-pub07/JC1254-HighCoverageIDU_en.pdf.
4. Buxton J.A., Preston E.C., Mak S., Harvard S., Barley J., BC Harm Reduction Strategies and Services Committee More than just needles: An evidence-informed approach to enhancing harm reduction supply distribution in British Columbia. Harm Reduction Journal 2008, 5(37). 10.1186/1477-7517-5-37.
5. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.C., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. Journal of the American Medical Association 1999, 282(15):1458-1465.
6. Caflisch C., Wang J., Zbinden R. The role of syringe filters in harm reduction among injection drug users. American Journal of Public Health 1999, 89(8):1252-1254.
7. Davis D.A., Taylor-Vaisey A. Translating guidelines into practice: A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Canadian Medical Association Journal 1997, 157(4):408-416.
8. DeBeck K., Kerr T., Li K., Fischer B., Buxton J., Montaner J., et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. Canadian Medical Association Journal 2009, 181(9):585-589.
9. Des Jarlais D.C., McKnight C., Goldblatt C., Purchase D. Doing harm reduction better: Syringe exchange in the United States. Addiction 2009, 104(9):1441-1446.
10. Dillman D.A. Mail and internet surveys: The tailored design method 2000, John Wiley, New York. 2nd ed.
11. Fischer B., Powis J., Cruz M.F., Rudzinski K., Rehm J. Hepatitis C virus transmission among oral crack users: Viral detection on crack paraphernalia. European Journal of Gastroenterology and Hepatology 2008, 20(1):29-32.
12. Garden J., Roberts K., Taylor A., Robinson D. Evaluation of the provision of single use citric acid sachets to injecting drug users 2003, Effective Interventions Unit, Scottish Centre for Infection and Environmental Health, Edinburgh, Retrieved from Drug Misuse Information Scotland website:. http://www.drugmisuse.isdscotland.org/eiu/pdfs/citric_acid_full.pdf.
13. Haines A., Kuruvilla S., Borchert M. Bridging the implementation gap between knowledge and action for health. Bulletin of the World Health Organization 2004, 82(10):724-731.
14. Hankins C.A. Syringe exchange in Canada: Good but not enough to stem the HIV tide. Substance Use and Misuse 1998, 33(5):1129-1146.
15. Haydon E., Fischer B. Crack use as a public health problem in Canada. Canadian Journal of Public Health 2005, 9(3):185-188.
16. Holtgrave D.R., Pinkerton S.D., Jones T.S., Lurie P., Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998, 18(S1):S133-S138.
17. Laufer F.N. Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes 2001, 28(3):273-278.
18. Leonard, L., DeRubeis, E., Germain, A., Prince, M., Medd, E., & Reynolds, A. (2008 February). Ontario Harm Reduction Distribution Program provincial report outcome evaluation wave one - baseline. Ottawa: HIV Prevention Research Team, Department of Epidemiology and Community Medicine, University of Ottawa. Retrieved from University of Ottawa, Faculty of Medicine website: http://www.medicine.uottawa.ca/epid/assets/documents/PROVINCIAL%20OHRDP%20Wave%201%20Evaluation%20Report%20FINAL(with%20reference).pdf.
19. Leonard L., DeRubeis E., Pelude L., Medd E., Birkett N., Seto J. " I inject less as I have easier access to pipes": Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy 2008, 19(3):255-264.
20. Macías J., Palacios R.B., Claro E., Vargas J., Vergara S., Mira J.A., et al. High prevalence of hepatitis C virus infection among noninjecting drug users: Association with sharing the inhalation implements of crack. Liver International 2008, 28(6):781-786.
21. McKnight C.A., Des Jarlais D.C., Perlis T., Eigo K., Krim M., Ruiz M., et al. Syringe exchange programs-United States, 2005. Morbidity and Mortality Weekly Report 2007, 56(44):1164-1167.
22. McMahon J., Tortu S. A potential hidden source of hepatitis C infection among noninjecting drug users. Journal of Psychoactive Drugs 2003, 35(4):455-460.
23. Millson P., Leonard L., Remis R., Strike C., Challacombe L. Injection drug use, HIV and HCV infection in Ontario: The evidence 1992-2004 2005, HIV Social, Behavioural and Epidemiological Studies Unit, Faculty of Medicine, University of Toronto, Toronto, Retrieved from Ministry of Health and Long-Term Care website:. http://www.health.gov.on.ca/english/providers/pub/aids/reports/injection_druguse_hiv_hcv_infection_ontario_evi.pdf.
24. Ministry of Health and Long-Term Care Ontario public health standards 2008 2008, Retrieved from Ministry of Health and Long-Term Care website:. http://www.health.gov.on.ca/english/providers/program/pubhealth/oph_standards/ophs/progstds/pdfs/ophs_2008.pdf.
25. Nyamathi A.M., Dixon E.L., Robbins W., Smith C., Wiley D., Leake B., et al. Risk factors for hepatitis C virus infection among homeless adults. Journal of General Internal Medicine 2002, 17(2):134-143.
26. Ontario Needle Exchange Coordinating Committee. (Producer). (2006). The sleeping giant: A day in the life of a needle exchange program. Available from: http://www.ohtn.on.ca/Videos/sleeping%20giant.wmv.
27. Paone D., Clark J., Qiuhu S., Purchase D., Des Jarlais D.C. Syringe exchange in the United States, 1996: a national profile. American Journal of Public Health 1999, 89(1):43-46.
28. Parsons J., Hickman M., Turnbull P.J., McSweeney T., Stimson G.V., Judd A., et al. Over a decade of syringe exchange: Results from 1997 UK survey. Addiction 2002, 97(7):845-850.
29. Porter J., Bonilla L., Drucker E. Methods of smoking crack as a potential risk factor for HIV infection: Crack smokers' perceptions and behavior. Contemporary Drug Problems 1997, 24(2):319-347.
30. Pratt C-C.N.U., Paone D., Carter R.J., Layton M.C. Hepatitis C screening and management practices: A survey of drug treatment and syringe exchange programs in New York City. American Journal of Public Health 2002, 92(8):1254-1256.
31. Reid R. A benefit-cost analysis of syringe exchange programs. Journal of Health and Social Policy 2000, 11(4):41-57.
32. Remis, R. (2007). Unpublished raw data.
33. Statistics Canada Canada at a glance 2009 2009, Minister of Industry, Ottawa, Retrieved from Statistics Canada website:. http://www.statcan.gc.ca/pub/12-581-x/12-581-x2008001-eng.pdf.
34. Strike, C. (2008). Unpublished raw data.
35. Strike C., Challacombe L., Myers T., Millson M. Needle exchange programs: Delivery and access issues. Canadian Journal of Public Health 2002, 93(5):339-343.
36. Strike C., Leonard L., Millson M., Anstice S., Berkeley N., Medd E. Ontario needle exchange programs: Best practice recommendations 2006, Ontario Needle Exchange Coordinating Committee, Toronto.
37. Strike C., Myers T., Millson M. Finding a place for needle exchange programs. Critical Public Health 2004, 14(3):261-275.
38. Strike C., Wenghofer E., Gnam W., Hillier W., Veldhuizen S., Millson M. Physician peer assessments for compliance with methadone maintenance treatment guidelines. Journal of Continuing Education in the Health Professions 2007, 27(4):208-213.
39. Tortu S., McMahon J.M., Pouget E.R., Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Substance Use and Misuse 2004, 39(2):211-224.
40. Tortu S., Neaigus A., McMahon J., Hagen D. Hepatitis C among noninjecting drug users: A report. Substance Use and Misuse 2001, 36(4):523-534.
41. World Health Organization Policy brief: Provision of sterile injecting equipment to reduce HIV transmission 2004, Retrieved from World Health Organization website:. http://www.who.int/hiv/pub/advocacy/en/provisionofsterileen.pdf.
42. Wodak A., Cooney A. Effectiveness of sterile needle and syringe programmes. International Journal of Drug Policy 2005, 16S:S31-S44.